Bellerophon Therapeutics, Inc.
Bellerophon Therapeutics, Inc. (BLPH) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BLPH · as of Jun 9, 2026
Key Statistics
Explore Bellerophon Therapeutics, Inc. Data
blph stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 87.5%
Competitors & Peers
blph competitorsBLPH
ATLN
BCDA
HSTO
IMTX
KERNStock Performance
Full HistoryAbout Bellerophon Therapeutics, Inc.
Bellerophon Therapeutics, Inc. is a U.S.-based clinical-stage pharmaceutical company primarily focused on developing novel therapies for various cardiopulmonary conditions. Its flagship product is INO…
what is bellerophon therapeutics, inc. · blph stock overview · bellerophon therapeutics, inc. company profile · who is bellerophon therapeutics, inc. ceo · blph NASDAQ · bellerophon therapeutics, inc. headquarters · bellerophon therapeutics, inc. business segments
About Stock Overview & Key Data
Bellerophon Therapeutics, Inc. (BLPH) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 13, 2015. As of the latest trading session, BLPH stock price is $0.01, with a market capitalization of $146,791. The stock has returned -81.27% over the past 12 months and +0.00% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Bellerophon Therapeutics, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2022, Bellerophon Therapeutics, Inc. reported revenue of — and net income of -$19.8M. For detailed data — including Bellerophon Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Bellerophon Therapeutics, Inc. (BLPH) stock price is $0.01. The stock is traded on NASDAQ under the ticker symbol BLPH. The 52-week range is $0.01 – $0.10.